Home » Finance

Image for Wells Fargo & Company Cuts Clorox (NYSE:CLX) Price Target to $90.00

Wells Fargo & Company Cuts Clorox (NYSE:CLX) Price Target to $90.00

Clorox (NYSE:CLX – Free Report) had its price target cut by Wells Fargo & Company from $102.00 to $90.00 in a research report report published on Friday,Benzinga reports. They currently have an equal weight rating on the... More of this article »
Image for Wall Street Zen Downgrades Kilroy Realty (NYSE:KRC) to Sell

Wall Street Zen Downgrades Kilroy Realty (NYSE:KRC) to Sell

Kilroy Realty (NYSE:KRC – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday, Wall Street Zen reports. A... More of this article »
Image for Finance of America Companies (NYSE:FOA) Rating Lowered to Sell at Wall Street Zen

Finance of America Companies (NYSE:FOA) Rating Lowered to Sell at Wall Street Zen

Finance of America Companies (NYSE:FOA – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday,... More of this article »
Image for The Goldman Sachs Group (NYSE:GS) Lowered to “Hold” Rating by Wall Street Zen

The Goldman Sachs Group (NYSE:GS) Lowered to “Hold” Rating by Wall Street Zen

Wall Street Zen downgraded shares of The Goldman Sachs Group (NYSE:GS – Free Report) from a buy rating to a hold rating in a report issued on Sunday morning,Wall Street Zen reports. Several other brokerages have also recently... More of this article »
Image for Vertex Pharmaceuticals’ (VRTX) Overweight Rating Reiterated at JPMorgan Chase & Co.

Vertex Pharmaceuticals’ (VRTX) Overweight Rating Reiterated at JPMorgan Chase & Co.

JPMorgan Chase & Co. reaffirmed their overweight rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a report issued on Friday,Benzinga reports. They currently have a $560.00 target price on the pharmaceutical... More of this article »
Image for Wall Street Zen Upgrades Equinor ASA (NYSE:EQNR) to “Strong-Buy”

Wall Street Zen Upgrades Equinor ASA (NYSE:EQNR) to “Strong-Buy”

Equinor ASA (NYSE:EQNR – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a note issued to investors on Saturday, Wall Street Zen reports. A... More of this article »
Image for Wall Street Zen Downgrades Kestra Medical Technologies (NASDAQ:KMTS) to Sell

Wall Street Zen Downgrades Kestra Medical Technologies (NASDAQ:KMTS) to Sell

Kestra Medical Technologies (NASDAQ:KMTS – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday, Wall Street Zen reports. Other... More of this article »
Image for Enovis (NYSE:ENOV) Stock Rating Upgraded by Wall Street Zen

Enovis (NYSE:ENOV) Stock Rating Upgraded by Wall Street Zen

Enovis (NYSE:ENOV – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday, Wall Street Zen reports. Several... More of this article »
Image for Cognyte Software (NASDAQ:CGNT) Raised to Buy at Wall Street Zen

Cognyte Software (NASDAQ:CGNT) Raised to Buy at Wall Street Zen

Cognyte Software (NASDAQ:CGNT – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday, Wall... More of this article »
Image for Portage Biotech (NASDAQ:ALP) Stock Rating Upgraded by Wall Street Zen

Portage Biotech (NASDAQ:ALP) Stock Rating Upgraded by Wall Street Zen

Portage Biotech (NASDAQ:ALP – Get Free Report) was upgraded by research analysts at Wall Street Zen to a “hold” rating in a research note issued to investors on Saturday, Wall Street Zen reports. Several other equities... More of this article »
Image for Avalo Therapeutics (NASDAQ:AVTX) Stock Rating Lowered by Wall Street Zen

Avalo Therapeutics (NASDAQ:AVTX) Stock Rating Lowered by Wall Street Zen

Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday, Wall Street Zen reports. A number of... More of this article »
Image for Duluth (NASDAQ:DLTH) Raised to Buy at Wall Street Zen

Duluth (NASDAQ:DLTH) Raised to Buy at Wall Street Zen

Duluth (NASDAQ:DLTH – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday, Wall Street Zen... More of this article »
Image for Westlake (NYSE:WLK) Earns Overweight Rating from Analysts at KeyCorp

Westlake (NYSE:WLK) Earns Overweight Rating from Analysts at KeyCorp

KeyCorp started coverage on shares of Westlake (NYSE:WLK – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $92.00 price target on the specialty... More of this article »
Image for Western New England Bancorp (NASDAQ:WNEB) Stock Rating Upgraded by Wall Street Zen

Western New England Bancorp (NASDAQ:WNEB) Stock Rating Upgraded by Wall Street Zen

Western New England Bancorp (NASDAQ:WNEB – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors... More of this article »
Image for Wall Street Zen Upgrades Old Dominion Freight Line (NASDAQ:ODFL) to Buy

Wall Street Zen Upgrades Old Dominion Freight Line (NASDAQ:ODFL) to Buy

Old Dominion Freight Line (NASDAQ:ODFL – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday, Wall Street... More of this article »
Image for Three Lions Acquisition (NASDAQ:TLACU) Raised to “Hold” at Wall Street Zen

Three Lions Acquisition (NASDAQ:TLACU) Raised to “Hold” at Wall Street Zen

Three Lions Acquisition (NASDAQ:TLACU – Get Free Report) was upgraded by analysts at Wall Street Zen to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports. Three Lions Acquisition Price... More of this article »
Image for Radcom (NASDAQ:RDCM) Raised to “Hold” at Wall Street Zen

Radcom (NASDAQ:RDCM) Raised to “Hold” at Wall Street Zen

Radcom (NASDAQ:RDCM – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports. Several... More of this article »
Image for Robert W. Baird Cuts Copart (NASDAQ:CPRT) Price Target to $38.00

Robert W. Baird Cuts Copart (NASDAQ:CPRT) Price Target to $38.00

Copart (NASDAQ:CPRT – Free Report) had its price objective trimmed by Robert W. Baird from $42.00 to $38.00 in a research report sent to investors on Friday, Marketbeat reports. The firm currently has an outperform rating on... More of this article »
Image for Adobe’s (ADBE) Neutral Rating Reiterated at BTIG Research

Adobe’s (ADBE) Neutral Rating Reiterated at BTIG Research

BTIG Research restated their neutral rating on shares of Adobe (NASDAQ:ADBE – Free Report) in a report released on Friday morning,Benzinga reports. Other analysts also recently issued reports about the stock. Robert W. Baird... More of this article »
Image for CRH (NYSE:CRH) Research Coverage Started at Morgan Stanley

CRH (NYSE:CRH) Research Coverage Started at Morgan Stanley

Morgan Stanley initiated coverage on shares of CRH (NYSE:CRH – Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. The brokerage issued an overweight rating and a $139.00 price target on the... More of this article »
Image for Anpario (LON:ANP) Price Target Raised to GBX 600

Anpario (LON:ANP) Price Target Raised to GBX 600

Anpario (LON:ANP – Free Report) had its target price upped by Canaccord Genuity Group from GBX 570 to GBX 600 in a research report report published on Friday, Marketbeat.com reports. They currently have a buy rating on the stock. Separately,... More of this article »
Image for Exagen (NASDAQ:XGN) Research Coverage Started at B. Riley Financial

Exagen (NASDAQ:XGN) Research Coverage Started at B. Riley Financial

B. Riley Financial began coverage on shares of Exagen (NASDAQ:XGN – Free Report) in a report published on Friday morning. The firm issued a buy rating and a $12.00 target price on the stock. A number of other equities research... More of this article »
Image for DA Davidson Cuts Brinker International (NYSE:EAT) Price Target to $240.00

DA Davidson Cuts Brinker International (NYSE:EAT) Price Target to $240.00

Brinker International (NYSE:EAT – Free Report) had its price objective cut by DA Davidson from $260.00 to $240.00 in a research report report published on Friday morning,Benzinga reports. They currently have a neutral rating... More of this article »
Image for Angi (NASDAQ:ANGI) Research Coverage Started at JPMorgan Chase & Co.

Angi (NASDAQ:ANGI) Research Coverage Started at JPMorgan Chase & Co.

JPMorgan Chase & Co. began coverage on shares of Angi (NASDAQ:ANGI – Free Report) in a research note released on Friday morning, Marketbeat Ratings reports. The brokerage issued an underweight rating on the technology company’s... More of this article »
Image for Citigroup Cuts Clorox (NYSE:CLX) Price Target to $97.00

Citigroup Cuts Clorox (NYSE:CLX) Price Target to $97.00

Clorox (NYSE:CLX – Free Report) had its price target trimmed by Citigroup from $100.00 to $97.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a neutral rating on the stock. Several... More of this article »